Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 2
2016 3
2017 4
2018 10
2019 15
2020 19
2021 18
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Albumins represent highly cross-reactive animal allergens.
Liu Z, Trifonova D, Tulaeva I, Riabova K, Karsonova A, Kozlov E, Elisyutina O, Khaitov M, Focke-Tejkl M, Chen TH, Karaulov A, Valenta R. Liu Z, et al. Among authors: khaitov m. Front Immunol. 2023 Oct 20;14:1241518. doi: 10.3389/fimmu.2023.1241518. eCollection 2023. Front Immunol. 2023. PMID: 37928538 Free PMC article. Review.
Recombinant PreS-fusion protein vaccine for birch pollen and apple allergy.
Khaitov M, Shilovskiy I, Valenta R, Weber M, Korneev A, Tulaeva I, Gattinger P, van Hage M, Hofer G, Konradsen JR, Keller W, Akinfenwa O, Poroshina A, Ilina N, Fedenko E, Elisyutina O, Litovkina A, Smolnikov E, Nikonova A, Rybalkin S, Aldobaev V, Smirnov V, Shershakova N, Petukhova O, Kudlay D, Shatilov A, Timofeeva A, Campana R, Udin S, Skvortsova V. Khaitov M, et al. Allergy. 2024 Apr;79(4):1001-1017. doi: 10.1111/all.15919. Epub 2023 Oct 19. Allergy. 2024. PMID: 37855043
Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.
Brazhnikov G, Smolnikov E, Litovkina A, Jiang T, Shatilov A, Tulaeva I, Tulaev M, Karaulov A, Poroshina A, Zhernov Y, Focke-Tejkl M, Weber M, Akinfenwa O, Elisyutina O, Andreev S, Shilovskiy I, Shershakova N, Smirnov V, Fedenko E, Lepeshkova TS, Beltyukov EC, Naumova VV, Kundi M, Khaitov M, Wiedermann U, Valenta R, Campana R. Brazhnikov G, et al. Among authors: khaitov m. Allergy. 2023 Dec;78(12):3136-3153. doi: 10.1111/all.15865. Epub 2023 Sep 13. Allergy. 2023. PMID: 37701941 Free PMC article.
Antiviral Therapy of COVID-19.
Gudima G, Kofiadi I, Shilovskiy I, Kudlay D, Khaitov M. Gudima G, et al. Among authors: khaitov m. Int J Mol Sci. 2023 May 16;24(10):8867. doi: 10.3390/ijms24108867. Int J Mol Sci. 2023. PMID: 37240213 Free PMC article. Review.
Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®.
Rabdano SO, Ruzanova EA, Pletyukhina IV, Saveliev NS, Kryshen KL, Katelnikova AE, Beltyukov PP, Fakhretdinova LN, Safi AS, Rudakov GO, Arakelov SA, Andreev IV, Kofiadi IA, Khaitov MR, Valenta R, Kryuchko DS, Berzin IA, Belozerova NS, Evtushenko AE, Truhin VP, Skvortsova VI. Rabdano SO, et al. Among authors: khaitov mr. Vaccines (Basel). 2023 Apr 20;11(4):874. doi: 10.3390/vaccines11040874. Vaccines (Basel). 2023. PMID: 37112786 Free PMC article.
Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation.
Khaitov M, Nikonova A, Kofiadi I, Shilovskiy I, Smirnov V, Elisytina O, Maerle A, Shatilov A, Shatilova A, Andreev S, Sergeev I, Trofimov D, Latysheva T, Ilyna N, Martynov A, Rabdano S, Ruzanova E, Savelev N, Pletiukhina I, Safi A, Ratnikov V, Gorelov V, Kaschenko V, Kucherenko N, Umarova I, Moskaleva S, Fabrichnikov S, Zuev O, Pavlov N, Kruchko D, Berzin I, Goryachev D, Merkulov V, Shipulin G, Udin S, Trukhin V, Valenta R, Skvortsova V. Khaitov M, et al. Allergy. 2023 Jun;78(6):1639-1653. doi: 10.1111/all.15663. Epub 2023 Feb 14. Allergy. 2023. PMID: 36721963 Clinical Trial.
80 results